Adeia Inc. - ADEA

ADEA Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
ADEA	1.3	-3.0	-10.0	3.6	9.0	18.3	177.3	161.0	31.0	164.2
S&P 500	1.0	1.8	-0.9	2.7	7.3	26.5	31.0	80.1	196.5	33856.2

Compare ADEA with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	ADEA
name	Adeia Inc.
price	12.92
changes percentage	1.2539
change	0.16
day low	12.89
day high	13.09
year high	14.75
year low	9.6801
market cap	1347142560
price avg 50	13.054
price avg 200	11.88295
exchange	NASDAQ
volume	309452
avg volume	535834
open	13.04
previous close	12.76
eps	0.37
pe	34.92
earnings announcement	2025-02-18T21:00:00.000+0000
shares outstanding	104268000
timestamp	2025-01-17 21:00:01

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 58.7%

Overall Quarterly Financial Health: 50.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001803696
revenue	388788000	438933000	-11.42
gross profit	388788000	324712000	19.73
gross profit ratio	1	0.74	35.18
research and development expenses	54264000	44579000	21.73
operating expenses	252558000	277286000	-8.92
interest income	0	45335000	-100.00
interest expense	62574000	45335000	38.03
ebitda	237824000	269328000	-11.70
ebitdaratio	0.61	0.74	-17.15
operating income	136230000	153060000	-11.00
operating income ratio	0.35	0.35	0.48
net income	67372000	138392000	-51.32
net income ratio	0.17	0.32	-45.04
eps	0.63	1.33	-52.63

Overall Score of Annual Income Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 389 million in 2023 from 439 million in 2022 representing a change of -11.42%. This indicates a sales shrinking, which is a negative sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 238 million in 2023 from 269 million in 2022 representing a change of -11.7%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 136 million in 2023 from 153 million in 2022 representing a change of -11.0%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Earnings per Share (EPS): EPS increased to 0.63 in 2023 from 0.63 in 2022 representing a change of -52.63%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 389 million in 2023 from 325 million in 2022 representing a change of 19.73%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 54 million in 2023 from 45 million in 2022 representing a change of 21.73%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 253 million in 2023 from 277 million in 2022 representing a change of -8.92%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  Net Income: Net income increased to 67 million in 2023 from 138 million in 2022 representing a change of -51.32%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001803696
revenue	86101000	87350000	-1.43
gross profit	86101000	66830000	28.84
gross profit ratio	1	0.77	30.70
research and development expenses	14825000	14799000	0.18
operating expenses	57980000	38926000	48.95
interest income	0	0	NaN
interest expense	12758000	13296000	-4.05
ebitda	44899000	45137000	-0.53
ebitdaratio	0.52	0.55	-5.93
operating income	28121000	27904000	0.78
operating income ratio	0.33	0.32	2.24
net income	19314000	8382000	130.42
net income ratio	0.22	0.1	133.76
eps	0.18	0.08	133.46

Overall Score of Quarterly Income Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 86 million in 2024Q3 from 87 million in 2024Q2 representing a change of -1.43%. This indicates a sales shrinking, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 58 million in 2024Q3 from 39 million in 2024Q2 representing a change of 48.95%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 45 million in 2024Q3 from 45 million in 2024Q2 representing a change of -0.53%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Net Income: Net income decreased to 19 million in 2024Q3 from 8 million in 2024Q2 representing a change of 130.42%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 86 million in 2024Q3 from 67 million in 2024Q2 representing a change of 28.84%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 15 million in 2024Q3 from 15 million in 2024Q2 representing a change of 0.18%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 28 million in 2024Q3 from 28 million in 2024Q2 representing a change of 0.78%. The increase in operating income indicates better operational performance and increased profitability.

  Earnings per Share (EPS): EPS increased to 0.18 in 2024Q3 from 0.18 in 2024Q2 representing a change of 133.46%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001803696
total assets	1105556000	1210526000	-8.67
total liabilities	748934000	909114000	-17.62
total equity	356622000	301412000	18.32
cash and cash equivalents	54560000	114555000	-52.37
short term investments	29012000	0	NaN
long term investments	1	154384000	-100.00
total current assets	205842000	258713000	-20.44
total non current assets	899714000	951813000	-5.47
total current liabilities	102038000	160675000	-36.49
total non current liabilities	646896000	748439000	-13.57
common stock	121000	117000	3.42
retained earnings	-56325000	-123697000	54.47
total debt	595928000	734187000	-18.83

Overall Score of Annual Balance Sheet

0.7 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1,106 million in 2023 from 1,211 million in 2022 representing a change of -8.67%. Suggesting a decrease in asset holdings.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 55 million in 2023 from 115 million in 2022 representing a change of -52.37%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 206 million in 2023 from 259 million in 2022 representing a change of -20.44%. This indicates a worsen liquidity position.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 749 million in 2023 from 909 million in 2022 representing a change of -17.62%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 357 million in 2023 from 301 million in 2022 representing a change of 18.32%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 29 million in 2023 from 0 million in 2022 representing a change of nan%. This indicates an increase in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities decreased to 102 million in 2023 from 161 million in 2022 representing a change of -36.49%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 0 in 2023 from 0 in 2022 representing a change of 3.42%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -56 million in 2023 from -124 million in 2022 representing a change of 54.47%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 596 million in 2023 from 734 million in 2022 representing a change of -18.83%. This indicates a reduction in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001803696
total assets	1083165000	1068674000	1.36
total liabilities	704950000	709538000	-0.65
total equity	378215000	359136000	5.31
cash and cash equivalents	60698000	66453999	-8.66
short term investments	28486000	27997000	1.75
long term investments	0	64875000	-100.00
total current assets	244710000	219383000	11.54
total non current assets	838455000	849290999	-1.28
total current liabilities	71498000	73223000	-2.36
total non current liabilities	633452000	636315000	-0.45
common stock	124000	123000	0.81
retained earnings	-27730000	-47044000	41.06
total debt	533924000	545404000	-2.10

Overall Score of Quarterly Balance Sheet

0.9 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 1,083 million in 2024Q3 from 1,069 million in 2024Q2 representing a change of 1.36%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 705 million in 2024Q3 from 710 million in 2024Q2 representing a change of -0.65%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 378 million in 2024Q3 from 359 million in 2024Q2 representing a change of 5.31%. This indicates an increase in shareholders' equity.

  Short Term Investments: Short Term Investments increased to 28 million in 2024Q3 from 28 million in 2024Q2 representing a change of 1.75%. This indicates an increase in short-term investment holdings.

  Total Current Assets: Total Current Assets increased to 245 million in 2024Q3 from 219 million in 2024Q2 representing a change of 11.54%. This indicates a better liquidity position.

  Total Current Liabilities: Total Current Liabilities decreased to 71 million in 2024Q3 from 73 million in 2024Q2 representing a change of -2.36%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 0 in 2024Q3 from 0 in 2024Q2 representing a change of 0.81%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to -28 million in 2024Q3 from -47 million in 2024Q2 representing a change of 41.06%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 534 million in 2024Q3 from 545 million in 2024Q2 representing a change of -2.1%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 61 million in 2024Q3 from 66 million in 2024Q2 representing a change of -8.66%. This indicates a decrease in available liquid assets.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001803696
net change in cash	-59995000	-86566000	30.69
operating cash flow	152755000	183023000	-16.54
free cash flow	146412000	170157000	-13.95
capital expenditure	-6343000	-12866000	50.70
depreciation and amortization	95274000	160387000	-40.60
deferred income tax	11392000	-51030000	122.32
stock based compensation	18057000	52626000	-65.69
accounts payables	-894000	18601000	-104.81
inventory	0	0	NaN
acquisitions net	0	-50473000	100.00
investments in property plant and equipment	0	-12866000	100.00
net cash used for investing activites	-34488000	-2913000	-1083.93
debt repayment	-148000000	-40500000	-265.43
common stock issued	0	0	NaN
common stock repurchased	-11274000	-33201000	66.04
dividends paid	-21339000	-203816000	89.53
net cash used provided by financing activities	-178262000	-263257000	32.29
cash at end of period	54560000	114555000	-52.37
accounts receivables	0	24892000	-100.00
cash at beginning of period	114555000	201121000	-43.04

Overall Score of Annual Cashflow Statement

0.56 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -60 million in 2023 from -87 million in 2022 representing a change of 30.69%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Stock-Based Compensation: Stock-Based Compensation decreased to 18 million in 2023 from 53 million in 2022 representing a change of -65.69%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 1 million in 2023 from 19 million in 2022 representing a change of -104.81%. This indicates that the company has reduced its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables decreased to 0 million in 2023 from 25 million in 2022 representing a change of -100.0%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

  Dividends Paid: Dividends Paid increased to -21 million in 2023 from -204 million in 2022 representing a change of 89.53%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

• 📉 Negative Indicators

  Operating Cash Flow: Operating Cash Flow decreased to 153 million in 2023 from 183 million in 2022 representing a change of -16.54%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 146 million in 2023 from 170 million in 2022 representing a change of -13.95%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to -6 million in 2023 from -13 million in 2022 representing a change of 50.7%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 11 million in 2023 from -51 million in 2022 representing a change of 122.32%. This indicates that the company's tax liability for future periods has increased.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0001803696
operating cash flow	14311000	23461000	-39.00
free cash flow	14251000	23040000	-38.15
capital expenditure	-60000	-421000	85.75
depreciation and amortization	14126000	20520000	-31.16
deferred income tax	1778000	-548000	424.45
stock based compensation	7419000	6592000	12.55
accounts receivables	-13845000	-3909000	-254.18
accounts payables	2694000	-56000	4910.71
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	6942000	-421000	1748.93
net cash used for investing activites	-153000	2747000	-105.57
debt repayment	-12014000	-12014000	0.00
common stock issued	0	0	NaN
common stock repurchased	-2458000	-1373000	-79.02
dividends paid	-5450000	-5433000	-0.31
net cash used provided by financing activities	-19914000	-17778000	-12.01
net change in cash	-5756000	8429999	-168.28
cash at end of period	60698000	66453999	-8.66
cash at beginning of period	66454000	58024000	14.53

Overall Score of Quarterly Cashflow Statement

0.11 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -6 million in 2024Q3 from 8 million in 2024Q2 representing a change of -168.28%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 14 million in 2024Q3 from 23 million in 2024Q2 representing a change of -39.0%. This indicates that the company generated less cash from its core business operations.

  Free Cash Flow: Free Cash Flow decreased to 14 million in 2024Q3 from 23 million in 2024Q2 representing a change of -38.15%. This indicates a decrease in cash generated after accounting for capital expenditures.

  Capital Expenditure: Capital Expenditure increased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of 85.75%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 2 million in 2024Q3 from -1 million in 2024Q2 representing a change of 424.45%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 7 million in 2024Q3 from 7 million in 2024Q2 representing a change of 12.55%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables increased to 3 million in 2024Q3 from 0 million in 2024Q2 representing a change of 4910.71%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Dividends Paid: Dividends Paid decreased to -5 million in 2024Q3 from -5 million in 2024Q2 representing a change of -0.31%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Accounts Receivables: Accounts Receivables decreased to -14 million in 2024Q3 from -4 million in 2024Q2 representing a change of -254.18%. This suggests that the company has been able to collect payments from its customers more efficiently and timely.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	3.65	4.21	-13.27
net income per share	0.63	1.33	-52.33
operating cash flow per share	1.43	1.75	-18.28
free cash flow per share	1.37	1.63	-15.75
cash per share	0.78	1.1	-28.56
book value per share	3.35	2.89	15.85
tangible book value per share	-2.85	-4.26	33.02
shareholders equity per share	3.35	2.89	15.85
interest debt per share	6.18	7.47	-17.28
market cap	1320204060	989105280	33.47
enterprise value	1861572060	1608737280	15.72
pe ratio	19.6	7.15	174.18
price to sales ratio	3.4	2.25	50.69
pocfratio	8.64	5.4	59.92
pfcf ratio	9.02	5.81	55.12
pb ratio	3.7	3.28	12.81
ptb ratio	3.7	3.28	12.81
ev to sales	4.79	3.67	30.64
enterprise value over ebitda	7.83	5.97	31.05
ev to operating cash flow	12.19	8.79	38.65
ev to free cash flow	12.71	9.45	34.48
earnings yield	0.05	0.14	-63.53
free cash flow yield	0.11	0.17	-35.53
debt to equity	1.67	2.44	-31.40
debt to assets	0.54	0.61	-11.12
net debt to ebitda	2.28	2.3	-1.06
current ratio	2.02	1.61	25.29
interest coverage	2.18	3.38	-35.52
income quality	2.27	-0.61	469.90
dividend yield	0.02	0.21	-92.16
payout ratio	0.32	1.47	-78.49
sales general and administrative to revenue	0.22	0.3	-26.49
research and ddevelopement to revenue	0.14	0.1	37.43
intangibles to total assets	0.6	0.62	-3.02
capex to operating cash flow	0.04	0.07	-40.93
capex to revenue	0.02	0.03	-44.34
capex to depreciation	0.07	0.08	-17.01
stock based compensation to revenue	0.05	0.12	-61.26
graham number	6.9	9.29	-25.69
roic	0.11	0.17	-35.44
return on tangible assets	0.15	0.3	-49.17
graham net net	-5.44	-6.66	18.41
working capital	103804000	98038000	5.88
tangible asset value	-304210000	-444724000	31.60
net current asset value	-543092000	-650401000	16.50
invested capital	781090999	854717000	-8.61
average receivables	123402000	176797000	-30.20
average payables	9084500	4497000	102.01
average inventory	0	2550500	-100.00
days sales outstanding	107.56	109.96	-2.18
days payables outstanding	0	27.31	-100.00
days of inventory on hand	0	0	NaN
receivables turnover	3.39	3.32	2.23
payables turnover	0	13.37	-100.00
inventory turnover	0	0	NaN
roe	0.19	0.46	-58.85
capex per share	0.06	0.12	-51.73

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.19 on 2023-12-31 from 0.46 on 2022-12-31, representing a change of -58.85%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 19.60 on 2023-12-31 from 7.15 on 2022-12-31, representing a change of 174.18%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 2.02 on 2023-12-31 from 1.61 on 2022-12-31, representing a change of 25.29%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Debt-to-Equity Ratio:

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
ADEA
calendar year	2024	2024	NaN
revenue per share	0.79	0.8	-1.76
net income per share	0.18	0.08	129.64
operating cash flow per share	0.13	0.22	-39.21
free cash flow per share	0.13	0.21	-38.36
cash per share	0.82	0.87	-5.90
book value per share	3.47	3.3	4.96
tangible book value per share	-2.14	-2.44	12.61
shareholders equity per share	3.47	3.3	4.96
interest debt per share	5.01	5.14	-2.48
market cap	1298606850	1217070400	6.70
enterprise value	1771832850	1696020401	4.47
pe ratio	16.81	36.3	-53.69
price to sales ratio	15.08	13.93	8.25
pocfratio	90.74	51.88	74.92
pfcf ratio	91.12	52.82	72.50
pb ratio	3.43	3.39	1.32
ptb ratio	3.43	3.39	1.32
ev to sales	20.58	19.42	5.99
enterprise value over ebitda	39.46	37.57	5.02
ev to operating cash flow	123.81	72.29	71.26
ev to free cash flow	124.33	73.61	68.90
earnings yield	0.01	0.01	115.95
free cash flow yield	0.01	0.02	-42.03
debt to equity	1.41	1.52	-7.04
debt to assets	0.49	0.51	-3.41
net debt to ebitda	10.54	10.61	-0.67
current ratio	3.42	3.0	14.24
interest coverage	2.2	2.1	5.03
income quality	0.74	2.8	-73.53
dividend yield	0.0	0.0	-5.99
payout ratio	0.28	0.65	-56.47
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.17	0.17	1.63
intangibles to total assets	0.56	0.58	-3.49
capex to operating cash flow	0.0	0.02	-76.64
capex to revenue	0.0	0.0	-85.54
capex to depreciation	0.0	0.02	-79.30
stock based compensation to revenue	0.09	0.08	14.18
graham number	3.72	2.39	55.25
roic	0.03	0.02	54.10
return on tangible assets	0.04	0.02	116.71
graham net net	-4.65	-4.86	4.44
working capital	173212000	146160000	18.51
tangible asset value	-232806000	-265485000	12.31
net current asset value	-460240000	-490155000	6.10
invested capital	799523000	786606000	1.64
average receivables	130572500	112679500	15.88
average payables	6252500	4821500	29.68
average inventory	0	0	NaN
days sales outstanding	152.13	119.11	27.72
days payables outstanding	0	21	-100.00
days of inventory on hand	0	0	NaN
receivables turnover	0.59	0.76	-21.71
payables turnover	0	4.29	-100.00
inventory turnover	0	0	NaN
roe	0.05	0.02	118.80
capex per share	0.0	0.0	-85.80

• Negative

  ROE: Return on Equity (ROE) increased to 0.05 on 2024-09-30 Q3 from 0.02 on 2024-06-30 Q2, representing a change of 118.80%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 16.81 on 2024-09-30 Q3 from 36.30 on 2024-06-30 Q2, representing a change of -53.69%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 3.42 on 2024-09-30 Q3 from 3.00 on 2024-06-30 Q2, representing a change of 14.24%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Since it's above 3, indicating poor management of working capital.

• Debt-to-Equity Ratio:

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Positive Sentiment: Discounted Cash Flow value is 19.68 which is higher than current price 12.92, indicates the company may be undervalued.